Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome
about
Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesVascular dysfunction in a mouse model of Rett syndrome and effects of curcumin treatmentKcne2 deletion creates a multisystem syndrome predisposing to sudden cardiac deathDisturbance of cardiac gene expression and cardiomyocyte structure predisposes Mecp2-null mice to arrhythmiasLoss of MeCP2 in the rat models regression, impaired sociability and transcriptional deficits of Rett syndrome.Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function.Preclinical research in Rett syndrome: setting the foundation for translational success.β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndromeTreatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs.Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgeneLoss of MeCP2 Causes Urological Dysfunction and Contributes to Death by Kidney Failure in Mouse Models of Rett Syndrome.Paradoxical physiological responses to propranolol in a Rett syndrome patient: a case reportThe relationship of Rett syndrome and MECP2 disorders to autism.Progressive Changes in a Distributed Neural Circuit Underlie Breathing Abnormalities in Mice Lacking MeCP2.Progress in Rett Syndrome: from discovery to clinical trialsEffects of ω-3 PUFAs supplementation on myocardial function and oxidative stress markers in typical Rett syndromeAlterations in the carnitine cycle in a mouse model of Rett syndrome.Rett syndrome and MeCP2.Stress response factors as hub-regulators of microRNA biogenesis: implication to the diseased heart.Hyperexcitability of Mesencephalic Trigeminal Neurons and Reorganization of Ion Channel Expression in a Rett Syndrome Model.Pathogenesis of Lethal Aspiration Pneumonia in Mecp2-null Mouse Model for Rett SyndromeA New Pathway for Sympathetic Cardioprotection in Heart Failure.Assessment of Caregiver Inventory for Rett Syndrome.Exclusive expression of MeCP2 in the nervous system distinguishes between brain and peripheral Rett syndrome-like phenotypes.Methyl-CpG binding-protein 2 function in cholinergic neurons mediates cardiac arrhythmogenesis.Late sodium current associated cardiac electrophysiological and mechanical dysfunction.Evaluation of QTc in Rett syndrome: Correlation with age, severity, and genotype.Rett Syndrome: Coming to Terms with Treatment
P2860
Q27023257-70EFC6F7-4190-4CA8-97B7-9570A11350F7Q27318090-E02726B2-BCD6-4501-862D-BDF0E58DF914Q28305511-E75F172F-4E8F-48CF-A958-17B01DE22554Q28648466-413A4630-5F4B-47EC-ADCD-D1F0E66FA9DAQ30367333-90B3CA6A-AFC9-4E70-A4BE-143FA75FDD22Q30435678-8B7EA328-7990-4155-8422-6A3B47A96CA0Q30527828-1BBFEBDD-0225-4DF7-B7C9-CE27BD1558B8Q33919634-ADAA1A53-FCCB-499C-91A1-6CAD38CF83BBQ35237722-F0398CEB-BC49-4974-8264-84B8F9DC057BQ35253188-8EA1C1F7-510C-4344-A9E2-A0B845EB17B3Q36187325-50FBF70B-BB8F-42D9-813A-B7FAC43AD913Q36207070-E5E35D5D-3D73-4C6C-9F51-E55E2F497E0FQ36443010-5CA99E59-669E-4E82-B587-032609BDF7BAQ36914329-E5D961AA-62B1-4912-91CA-F243AB5F46DEQ37218356-65805330-80C1-442C-9D4A-5A88B8BAB333Q37553799-E4D5F3EB-7B86-4068-8F39-0BF8D3EB0C83Q37620699-F931B47F-CBBD-4E19-AE1A-5144AC133941Q38194967-E9C3C966-7BF0-439B-9E0D-A1C377AB556DQ38667356-BD4C2599-82F8-45EF-A5DE-A61E8916DB1FQ39349418-EC4B9D99-E4BC-4CB0-B25E-290CE785EDDDQ41697077-066EE50C-5CB4-4C98-BA99-715E78C9C237Q43115266-E23BDADF-B62C-4825-BE27-2D7E5427D158Q46167683-425912A5-BFF8-4663-9887-BD7DEE0FF8A9Q46435116-CAB548D0-826F-435A-B435-622E3389CFABQ47870681-7FFAA263-D19F-4F87-BE8B-970C500406B3Q50061975-89531152-2986-42BF-A898-153A3BB13BAEQ54859095-63311CCE-0B2D-4A2D-8962-DFCCB9D0351EQ59047735-FB6CD0D2-55E7-4ED7-A2E7-3B6C142F73AF
P2860
Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome
@ast
Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome
@en
Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome
@nl
type
label
Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome
@ast
Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome
@en
Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome
@nl
prefLabel
Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome
@ast
Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome
@en
Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome
@nl
P2093
P2860
P50
P921
P3181
P1476
Pathogenesis of lethal cardiac ...... n for therapy in Rett syndrome
@en
P2093
Alan K Percy
Daniel G Glaze
David L Beavers
Elise Mike
Mark D McCauley
Steven Skinner
Teng-Wei Huang
Tiannan Wang
P2860
P304
P3181
P356
10.1126/SCITRANSLMED.3002982
P407
P577
2011-12-01T00:00:00Z